Breast Cancer Tumor care Observational programme
Study identifier:NIS-OAT-ARI-2007/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Breast cancer Tumor care patient observation programme
Medical condition
Post menopausal
Phase
N/A
Healthy volunteers
No
Study drug
anastrozole
Sex
Female
Actual Enrollment
200
Study type
Observational
Age
18 Years - 100 Years
Date
Study Start Date: 01 Feb 2008
Estimated Primary Completion Date: 01 Sept 2009
Estimated Study Completion Date: 01 Sept 2009
Study design
Allocation: Non-randomized
Endpoint Classification: -
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| 1 | Drug: anastrozole Oral Other Name: Arimidex |
Contacts
Investigators
Principal Investigator
Dr. Melichart
Hospital Rudolfstiftung
